Metallo-β-lactamase gene blaIMP-15 in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2943-2946

  Garza Ramos, U ^a   Morfin Otero, R ^b   Sader, H S ^c   Jones, R N ^c   Hernandez E ^a   Rodriguez Noriega, E ^b   Sanchez, A ^a   Carrillo, B ^a   Esparza Ahumada, S ^b   Silva Sanchez, J ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLA IMP 15 GENE; ENZYME SYNTHESIS; GENE; GENE CASSETTE; GENE INSERTION; INTEGRON; METALLO BETA LACTAMASE GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY HEALTH CARE;

BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INTEGRONS; MEXICO; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 48749129143     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00679-07     Document Type: Article

References (29)

1. VIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program. J. Clin. Microbiol. 45:614-615.
2. Adrian, P. V., C. J. Thomson, K. P. Klugman, and S. G. Amyes. 2000. New gene cassettes for trimethoprim resistance, dfr13, and streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron. Antimicrob. Agents Chemother. 44:355-361.
3. VEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob. Agents Chemother. 48:3284-3290.
4. G1M-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob. Agents Chemother. 48:4654-4661.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing. Document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Collis, C. M., and R. M. Hall. 1995. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob. Agents Chemother. 39:155-162.
7. Garza-Ramos, U., P. Tinoco, J. Silva-Sanchez, R. Morfin-Otero, E. Rodriguez-Noriega, G. Leon-Garnica, H. S. Sader, and R. N. Jones. 2008. Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int. J. Antimicrob. Agents 31:78-80.
8. Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:195-202.
9. Gu, B., M. Tong, W. Zhao, G. Liu, M. Ning, S. Pan, and W. Zhao. 2007. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J. Clin. Microbiol. 45:241-243.
10. Hall, R. M., C. M. Collis, M. J. Kim, S. R. Partridge, G. D. Recchia, and H. W. Stokes. 1999. Mobile gene cassettes and integrons in evolution. Ann. N. Y. Acad. Sci. 870:68-80.
11. 1MP. Antimicrob. Agents Chemother. 42:2006-2011.
12. Kaufmann, M. E. 1998. Pulse-field gel electrophoresis. Methods Mol. Med. 15:17-31.
13. Kieser, T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36.
14. Laupland, K. B., M. D. Parkins, D. L. Church, D. B. Gregson, T. J. Louie, J. M. Conly, S. Elsayed, and J. D. Pitout. 2005. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J. Infect. Dis. 192:1606-1612.
15. VIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
16. Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.
17. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485-4491.
18. Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
19. Martin, C. A., K. Morita, J. A. Ribes, L. M. Deshpande, H. S. Sader, and M. Castanheira. 2008. IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico. Antimicrob. Agents Chemother. 52:2289-2290.
20. Miller, J. 1972. Experiments in molecular genetics, p. 82-85. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Naas, T., L. Poirel, and P. Nordmann. 1999. Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa. Biochim. Biophys. Acta 1489:445-451.
22. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-beta-lactamase found in a clinical isolate of Senatia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
23. Pitout, J. D., B. L. Chow, D. B. Gregson, K. B. Laupland, S. Elsayed, and D. L. Church. 2007. Molecular epidemiology of metallo-beta-lactamase- producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J. Clin. Microbiol. 45:294-298.
24. Sader, H. S., M. Castanheira, R. E. Mendes, M. Toleman, T. R. Walsh, and R. N. Jones. 2005. Dissemination and diversity of metallo-beta- lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25:57-61.
25. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.
26. Smith, A. W., and B. H. Iglewski. 1989. Transformation of Pseudomonas aemginosa by electroporation. Nucleic Acids Res. 17:10509.
27. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
28. Toleman, M. A., A. M. Simm, T. A. Murphy, A. C. Gales, D. J. Biedenbach, R. N. Jones, and T. R. Walsh. 2002. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother. 50:673-679.
29. Walsh, T. R. 2005. The emergence and implications of metallo-beta-lactamases in gram-negative bacteria. Clin. Microbiol. Infect. 11(Suppl. 6):2-9.